Progeny Genetics, LLC offers an all-inclusive tool that uses family history data to nurture patients from diagnosis to cure. A subsidiary of Ambry Genetics, Progeny provides family history, pedigree, and genetic data management software to clinicians, researchers, and laboratories worldwide. Progeny Clinical is the gold standard clinical platform that enables quick management of family history data without the time-consuming and expensive costs of setting up and maintaining a secure database and infrastructure. The platform allows capturing data from patients through online family history questionnaires, automatically drawing family pedigrees, identifying at-risk individuals using validated risk assessment models, and ordering and tracking genetic testing. Progeny has gained trust from top healthcare and research institutions in 80 countries for its ability to collect and manage family history to determine inherited risk and deliver personalized treatment. Founded in 1996 and headquartered in the United States, Progeny Genetics, LLC remains an impactful player in the healthcare industry, attracting potential interest from venture capital firms seeking lucrative investment opportunities in the evolving healthcare tech sector.
There is no investment information
No recent news or press coverage available for Progeny Genetics, LLC.